JAYLON GARRETT: Open Payments
NPI 1306470166 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 9 payments from 7 companies in 2025. Trend: 2023 $36 · 2024 $648 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 1 | $109 |
| Ipsen Biopharmaceuticals, Inc | 1 | $108 |
| Janssen Biotech, Inc. | 1 | $98 |
| PFIZER INC. | 3 | $66 |
| Incyte Corporation | 1 | $28 |
| Astellas Pharma US Inc | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Onivyde, RYBREVANT, Xtandi, ZYNYZ, KEYTRUDA.
Industry payments across DC — which companies pay providers there.
